3185 results for «38075»

Filter By

3185 results

What an interventional cardiologist should know about anti-thrombotics

22 May 2025 – From EuroPCR 2025

This session provides comprehensive knowledge on anti-thrombotic management for interventional cardiologists, emphasizing effective inhibition during acute STEMI, latest evidence implementation for high bleeding risk patients, and customization of dual antiplatelet therapy in patients with high thrombotic and low bleeding risks through clinical cases and evidence-based recommendations.

What an interventional cardiologist should know about anti-thrombotics

Procedural planning and risk stratification in multivessel PCI

22 May 2025 – From EuroPCR 2025

This session focuses on procedural planning and risk stratification in multivessel PCI, presenting data from the TALENT and FIRE trials, prognostic value of post-PCI physiological assessments, and an innovative study comparing large language models in managing complex interventional cardiology cases.

Procedural planning and risk stratification in multivessel PCI

Multimodality imaging and physiology for MINOCA diagnosis

20 May 2025 – From EuroPCR 2025

This session highlights the power of multimodality imaging and physiology in diagnosing MINOCA. Topics include detecting hidden plaque vulnerability, managing unexpected diagnoses beyond MINOCA, decision-making on stenting, AI's added value, and lessons from recurrent cases.

Multimodality imaging and physiology for MINOCA diagnosis

How to deal with ostial right coronary artery CTOs

20 May 2025 – From EuroPCR 2025

Delve into specialized approaches for managing ostial right coronary artery CTOs. This session discusses scenarios with no clear antegrade path, PCI in high take-off anomalies, retrograde techniques in familial hypercholesterolemia, and complex in-stent CTOs with aortic protrusion.

How to deal with ostial right coronary artery CTOs

Hotline TAVI 1: extended analysis of the randomised trials

21 May 2025 – From EuroPCR 2025

Gain comprehensive insights from extended analyses of randomized TAVI trials. This session reviews five-year UK TAVI outcomes, cardiac damage evolution in asymptomatic aortic stenosis, one-year results from the LANDMARK trial, and three-year comparisons of balloon-expandable valves, highlighting critical clinical implications.

Hotline TAVI 1: extended analysis of the randomised trials

PCR's Got Talent - Round 2 - Session 1

21 May 2025 – From EuroPCR 2025

PCR's Got Talent Round 2 Session 1 showcases emerging talents and innovations in interventional cardiology, highlighting promising advancements and expert insights shaping the future of cardiovascular interventions.

PCR's Got Talent - Round 2 - Session 1

DCB in challenging scenarios - Part 2

20 May 2025 – From EuroPCR 2025

Explore the application of drug-coated balloons (DCB) in challenging coronary scenarios with a focus on recurrent calcified stenosis, in-stent restenosis, and left main interventions. This session includes case discussions on plaque phenotype-guided DCB treatment, 'leave nothing behind' strategy, and complex left main PCI using kissing DCBs...

DCB in challenging scenarios - Part 2

Simplify PCI! Know where and how to win with drug-coated balloon

22 May 2025 – From EuroPCR 2025

This session provides a comprehensive update on the use of drug-coated balloons (DCBs) to simplify percutaneous coronary intervention (PCI). It reviews various types of drugs, coatings, and balloon technologies used in DCBs, alongside the latest clinical data supporting their safety and efficacy. It also offers practical insights into...

Simplify PCI! Know where and how to win with drug-coated balloon

Complex multivessel disease - LIVE Case

21 May 2025 – From EuroPCR 2025

An 89-year-old male patient presented with stable angina, preserved LV function and some risk factors such as hypertension and diabetes. CT scan and angiography revealed occlusion of proximal RCA and bifurcation lesions on LAD and circumflex (medina 1,1,1). Operators treated the bifurcation lesions with provisional stenting.
Regarding...

Complex multivessel disease - LIVE Case

Out of the box: tackling complex peripheral intervention

23 May 2025 – From EuroPCR 2025

Explore unconventional approaches to complex peripheral interventions through case studies involving pulmonary arteriovenous malformations, splenic aneurysms, vascular complications post maxillofacial surgery, and cyanosis in structurally normal hearts, emphasizing diagnostic and therapeutic ingenuity.

Out of the box: tackling complex peripheral intervention

Paravalvular leak closure in TMVR

23 May 2025 – From EuroPCR 2025

This session addresses paravalvular leak closure in transcatheter mitral valve replacement, exploring multiple plug techniques, complex leak management, and combined antegrade and retrograde approaches, providing nuanced insights into challenging mitral prosthesis complications.

Paravalvular leak closure in TMVR

PCI for complex left main disease - LIVE Case

23 May 2025 – From EuroPCR 2025

An 82-year-old male patient with a history of STEMI and diagonal PCI (2004) presented with stable angina (CCS 2). CT imaging revealed 2 severe LAD stenoses (at the ostium and mid part), and a severe bifurcation stenosis at the Cx/OM1 confirmed by angiography. A staged PCI...

PCI for complex left main disease - LIVE Case

Transcatheter tricuspid valve replacement - LIVE Case

18 Nov 2025 – From PCR London Valves 2025

Live case: An 86-year-old male, with a history of PPM, permanent AF, CKD stage 3, and moderately impaired LV function (50–55%), presented with symptomatic torrential mixed TR (tricuspid annular dilatation and pacing lead on the septal leaflet). An Evoque valve was implanted under fluoroscopy and TEE...

Transcatheter tricuspid valve replacement - LIVE Case

Pills and pumps: targeting heart failure before and after surgical and transcatheter valve interventions

18 Nov 2025 – From PCR London Valves 2025

This session examines the integrated role of heart failure therapies in the peri- and post-procedural management of patients undergoing surgical and transcatheter valve interventions. It reviews current and emerging clinical trial data, discusses identifying high-risk patients, and explores advanced modalities such as cardiac resynchronization and circulatory...

Pills and pumps: targeting heart failure before and after surgical and transcatheter valve interventions

Getting to the heart of access: mastering femoral puncture and vascular closure

18 Nov 2025 – From PCR London Valves 2025

This session provides an in-depth understanding of femoral anatomy and the critical role of imaging in ensuring safe vascular access via femoral puncture. It covers the latest equipment used for vascular access and closure, highlighting haemostasis techniques and closure devices. Interactive case scenarios offer practical insights...

From GDMT to TEER: management of secondary mitral regurgitation and the timing of transcatheter intervention

18 Nov 2025 – From PCR London Valves 2025

Delve into the comprehensive management of secondary mitral regurgitation, from guideline-directed medical therapy (GDMT) to transcatheter edge-to-edge repair (TEER). This session elucidates the pathophysiology of atrial and ventricular secondary mitral regurgitation, explores optimized heart failure treatments, and reviews the latest evidence on TEER as a therapeutic...

From GDMT to TEER: management of secondary mitral regurgitation and the timing of transcatheter intervention

Featured research - Mitral valve interventions - Part 4

18 Nov 2025 – From PCR London Valves 2025

This research-focused session presents contemporary evidence and clinical outcomes related to mitral valve interventions. It includes data on transapical mitral valve-in-ring implantation from the European Tendyne registry, prognostic utility of CT-derived fatty muscle fraction in mitral TEER, and comparative outcomes between transapical TMVR and mitral TEER....

Iatrogenic atrial septum defect closure: a necessary procedure?

18 Nov 2025 – From PCR London Valves 2025

This session addresses the clinical considerations surrounding iatrogenic atrial septal defects (ASDs) resulting from transseptal procedures. It covers prevention of residual defects, diagnostic evaluation, criteria for closure, procedural timing, and management strategies for related complications, supported by illustrative clinical cases demonstrating decision-making nuances.

Paravalvular leak closure - Part 3

18 Nov 2025 – From PCR London Valves 2025

This session addresses the complexities of paravalvular leak closure, emphasizing resilience in procedural approaches. It covers sizing balloon techniques that enhance treatment efficacy in aortic paravalvular leaks and explores closure strategies following Ozaki procedures. Management of mitral paravalvular leaks in high-risk patients and innovative solutions for...

TAVI device selection and implantation - A perspective for nurses and allied professionals

18 Nov 2025 – From PCR London Valves 2025

This session offers an in-depth perspective tailored for nurses and allied professionals on TAVI device selection and implantation. It covers critical assessment techniques for aortic stenosis severity, detailed patient selection criteria, and step-by-step procedural insights. Additionally, it provides a comprehensive overview of valve options including self-expanding...

Didn’t find what you were looking for?